Thomas James E's Form 4 filing
Clarus Therapeutics Inc · filed Apr 21, 2022
- Accession no.
- 0001062993-22-010622
- Filed
- Apr 21, 2022, 7:04 PM ET
- Trade date
- Apr 20, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $9.49M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thomas James ECIK 0001204789 | 10% Owner |
| TMP Associates LPCIK 0001226280 | 10% Owner |
| Thomas McNerney & Partners LPCIK 0001231291 | 10% Owner |
| Thomas, McNerney & Partners, LLCCIK 0001335196 | 10% Owner |
| TMP Nominee, LLCCIK 0001335200 | 10% Owner |
| Thomas, McNerney & Partners II L.P.CIK 0001369574 | 10% Owner |
| TMP Associates II LPCIK 0001383035 | 10% Owner |
| TMP Nominee II, LLCCIK 0001436054 | 10% Owner |
| Thomas, McNerney & Partners II, LLCCIK 0001505930 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | Common Stock | SSaleDisposed | −1,663,126 | $2.53F1 | −$4,207,708.78 | 773,599 | Indirect | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −2,061,685 | $2.53F1 | −$5,216,063.05 | 958,989 | Indirect | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −5,722 | $2.53F1 | −$14,476.66 | 2,661 | Indirect | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −13,630 | $2.53F1 | −$34,483.9 | 6,340 | Indirect | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −1,164 | $2.53F1 | −$2,944.92 | 542 | Indirect | |
| Apr 20, 2022 | Common Stock | SSaleDisposed | −7,585 | $2.53F1 | −$19,190.05 | 3,528 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The prices reported in this column are weighted average prices at a range of prices between $2.20 and $3.03. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges of the prices reported.
Referenced by the price of 6 transactions in Table I.